Abstract
The objective of the present study was to evaluate the effect of Berberis aristata (BA) against oxazolone induced contact dermatitis in Balb/c mice and molecular docking with TLR-1 and TLR-2. Dermatitis was induced in Balb/c mice by sensitizing with topical application of 100 μl oxazolone (2%) and the effect of BA was screened in two doses (200 mg/kg and 400 mg/kg P.O.). The effect was evaluated by the change in ear thickness, anti-inflammatory cytokine (TNF-α, IL-6, and IL-1β) and oxidative stress on the sixth day in ear tissue homogenate. The ear skin of all group mice was subjected to histological analysis. This work was further evidenced by the docking of berberine with crystal structure of TLR1-TLR2 heterodimer caused by using the binding of tri-acylated lipopeptide (PDB ID: 2Z7X). In this study, we found that a significant reduction in ear thickness was found in BA (200 mg/kg and 400 mg/kg) as compared to 100 μl oxazolone(2%) treated mice. The reduction level of GSH and SOD found in 100 μl oxazolone (2%) sensitized mice. BA (200 mg/kg and 400 mg/kg) treated animals showed an increase in GSH and SOD levels. A significant reduction in inflammatory cytokines was observed in BA treated mice and indicates anti-inflammatory activity against oxazolone. Histopathological analysis showed minimal infiltration of lymphocytes and moderate harm to skin cells and layer in BA treated mice. Docking studies revealed promising binding interaction of berberine withTLR1-TLR2 heterodimer which can attribute to its anti dermatic effect. This present research shows that BA has a dose-dependent effect in contact dermatitis attenuated by oxazolone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data
All data and material are available upon request.
References
Alyoussef A (2018) Blocking TGF-β type 1 receptor partially reversed skin tissue damage in experimentally induced atopic dermatitis in mice. Cyto 106:45–53. https://doi.org/10.1016/j.cyto.2018.02.025
Chander V et al (2017) A review on Pharmacological potential of Berberine; an active component of Himalayan Berberis aristata. J Phytopharmacol 6(1):53–58
Chapman J, Ruben Z, Butchko G (1986) Histology of and quantitative assays for oxazolone-induced allergic contact dermatitis in mice. Am J Dermatopathol 8(2):130–138. https://doi.org/10.1097/00000372-198604000-00007
Charman C, Chambers C, Williams H (2003) Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Investi Dermatol 120(6):932–941. https://doi.org/10.1046/j.1523-1747.2003.12251.x
Corsini E, Galli CL (2000) Epidermal cytokines in experimental contact dermatitis. Toxicology 142(3):203–212. https://doi.org/10.1016/s0300-483x(99)00145-6
Fujii Y et al (2002) Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats. Eur J Pharmacol 456(1–3):115–121
Furue M, Kadono T (2017) “Inflammatory skin march” in atopic dermatitis and psoriasis. InflamRes 66(10):833–842. https://doi.org/10.1007/s00011-017-1065-z
Guttman-Yassky E, Nograles KE, Krueger JG (2011) Contrasting pathogenesis of atopic dermatitis and psoriasis—part I: clinical and pathologic concepts. J Aller Clin Immunol 127(5):1110–1118. https://doi.org/10.1016/j.jaci.2011.01.053
Jain PG, Mahajan UB, Shinde SD, Surana SJ (2018) Cardioprotective role of FA against isoproterenol induced cardiac toxicity. Mole Biol Rep 45(5):1357–1365. https://doi.org/10.1007/s11033-018-4297-2
Ji H, Li XK (2016) Oxidative stress in atopic dermatitis. Oxidat Med Cell Longevit. https://doi.org/10.1155/2016/2721469
Jung Y et al (2018) Eupatilin, an activator of PPARα, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice. Biochem Biophys Res Commu. 496(2):508–514. https://doi.org/10.1016/j.bbrc.2018.01.098
Kemeny A et al (2010) Pituitary adenylate cyclase-activating polypeptide deficiency enhances oxazolone-induced allergic contact dermatitis in mice. J Moler Neurosci 42(3):443–449. https://doi.org/10.1007/s12031-010-9368-3
Larsen JM et al (2009) IL-23 and TH17-mediated inflammation in human allergic contact dermatitis. J Aller Clin Immunol 123(2):486–492. https://doi.org/10.1016/j.jaci.2008.09.036
Lowes MA et al (2013) The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 34(4):174–181
Mangano K et al (2017) Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone. Experi Ther Medi 14(3):2439–2444. https://doi.org/10.3892/etm.2017.4810
Masule MV et al (2019) Evaluation of antioxidant and anti parkinsonism activity of betaine in experimental rats. J Drug Deli Therap 9:417–421. https://doi.org/10.22270/jddt.v9i2-s.2717
Matsumoto K et al (2004) Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments. Skin Res Technol 10(2):122–129. https://doi.org/10.1111/j.1600-0846.2004.00062.x
Menter A (2016) Psoriasis and psoriatic arthritis overview. Am J Manag Care 22(8):216–224
Oka S et al (2006) Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoyl glycerol in oxazolone-induced contact dermatitis in mice. J Immunol 177(12):8796–8805. https://doi.org/10.4049/jimmunol.177.12.8796
Pedretti A, Villa L, Vistoli G (2004) VEGA–an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J Comput Aid Mol Des 18(3):167–173. https://doi.org/10.1023/b:jcam.0000035186.90683.f2
Petersen TK (2006) In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery. Basic Clin Pharmacol Toxicol 99(2):104–115
Potdar D, Hirwani R, Dhulap S (2012) Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia 83(5):817–830. https://doi.org/10.1016/j.fitote.2012.04.012
Schmidt M, Goebeler M, Martin SF (2016) Methods to investigate the role of Toll-like receptors in allergic contact dermatitis. In: Toll-like receptors. Springer, Berlin, pp 319–340. https://doi.org/10.1007/978-1-4939-3335-8_20
Seeliger D, de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comp-aided Mol design. 24(5):417–422
Shin YW et al (2005) Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Interna Immunopharmacol 5(7–8):1183–1191. https://doi.org/10.1016/j.intimp.2005.02.016
Sreedevi A, Brarathi K (2010) Effect of decoction of root bark of Berberis Aristata against cisplatin induced nephrotoxicity in rats. Int J Pharmacy Pharm Sci 2(3):51–56
Tramposch KM (1999) Skin inflammation. In: In vivo models of inflammation. Springer, Berlin, pp 179–204
Vina A (2010) Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading Trott, Oleg; Olson, Arthur J. J Comput Chem 31(2):455–461. https://doi.org/10.1002/jcc.21334
Zheng T et al (2009) Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 129(3):742–751. https://doi.org/10.1038/jid.2008.295
Acknowledgements
The authors received no funding for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statement
The experimental protocol was approved by the institutional animal ethical committee with protocol no. RGCOP/IAEC/2019-20/06.
Conflict of interest
Sachin D. Shinde has no conflict of interest. Rameshwar S. Cheke has no conflict of interest. Prafulla R. Tathe has no conflict of interest. Pankaj G. Jain has no conflict of interest. Rohan R. Narkhede has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shinde, S.D., Cheke, R.S., Tathe, P.R. et al. The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences. ADV TRADIT MED (ADTM) 21, 685–692 (2021). https://doi.org/10.1007/s13596-020-00476-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-020-00476-0